11
. CryoLife does not undertake to update its forward-looking statements.CRYOLIFE, INC. AND SUBSIDIARIESFinancial Highlights(In thousands, except per share data)Three Months EndedSix Months EndedJune 30,June 30,June 30,June 30,2011201020112010(Unaudited)(Unaudited)Revenues:Preservation services
$14,688
$15,005$30,362
$30,588Products
14,580
14,14629,009
28,101Other
111
112204
291Total revenues29,37929,26359,57558,980Cost of preservation services and products:Preservation services
8,164
9,01317,360
18,411Products
2,162
2,4814,658
5,008Total cost of preservation services and products10,32611,49422,01823,419Gross margin19,05317,76937,55735,561Operating expenses:General, administrative, and marketing
13,659
11,67027,950
25,487Research and development
1,643
1,2403,409
2,532Total operating expenses15,30212,91031,35928,019Operating income3,7514,8596,1987,542Interest expense
37
6567
116Interest income
(3)
(6)(12)
(10)Gain on valuation of derivative
--
(385)--
(1,202)Other (income) expense, net
(62)
111(171)
231Income before income taxes3,7795,0746,3148,407Income tax expense
1,959
2,1482,828
3,547Net income$1,820
$2,926$3,486
$4,860Income per common share:Basic$0.07
$0.10
SOURCE CryoLife, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Related medicine technology :1.
CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results2.
CryoLife Makes Equity Investment in ValveXchange® Inc.3.
CryoLife Announces Completion of Acquisition of Cardiogenesis4.
CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation5.
CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation6.
CryoLife Posts Record Quarterly Revenues of $30.2 Million7.
CryoLife Launches BioGlue® Surgical Adhesive in Japan8.
CryoLife Announces Release Date and Teleconference Call Details for 2011 First Quarter Financial Results9.
CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation10.
CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation11.
CryoLife Signs Definitive Agreement to Acquire Cardiogenesis